Dr. François Robert, molecular biology researcher at the Institut de recherches cliniques de Montréal (IRCM), and his team confirmed that the phosphorylation of RNA polymerase II, a key enzyme in the process of gene expression, is uniform across all genes. This discovery, which contributes to numerous debates on the topic within the scientific community, will be published tomorrow in the scientific journal Molecular Cell.
Phosphorylation, or the addition of phosphate to a molecule, is one of the most important regulation mechanisms for cells. It allows, among other things, to control interactions between proteins.
"During transcription, the first step in gene expression, RNA polymerase II is abundantly phosphorylated," explains Dr. Robert, Director of the Chromatin and Genomic Expression research unit at the IRCM. "This allows for the coordination between transcription and the other steps in the process of gene expression."
By examining a small number of genes, certain pioneering studies that have been long-accepted in the field had shown that phosphorylation of RNA polymerase II always occurred in the same prescribed pattern during transcription. However, recent genome-wide analyses challenged this idea by suggesting that this process was not uniform across different genes. "The latter model is very controversial, because it is unclear how, or why, transcription could work in such radically different ways from one gene to the next," says Alain Bataille, doctoral student and first co-author of the study.
By using modern functional genomic tools, the team of researchers confirmed the former hypothesis that transcription operates in a uniform way across virtually all genes.
"The identity of enzymes responsible for adding and removing phosphate groups to RNA polymerase II is another controversial topic among scientists," adds Dr. Célia Jeronimo, postdoctoral fellow in Dr. Robert's laboratory and first co-author of the article. "Our research also allowed us to better understand the respective role of these essential enzymes."
About Dr. François Robert
François Robert obtained his PhD in molecular biology from the Université de Sherbrooke. He is Associate IRCM Research Professor, Director of the Systems Biology and Medicinal Chemistry research program, and Director of the Chromatin and Genomic Expression research unit. Dr. Robert is an associate researcher-professor in the Department of Medicine (accreditation in molecular biology) at the Université de Montréal. He is also adjunct professor in the Department of Biology at the Université de Sherbrooke.
About the Institut de recherches cliniques de Montréal (IRCM)
Founded in 1967, the IRCM (http://www.ircm.qc.ca) is currently comprised of 36 research units in various fields, namely immunity and viral infections, cardiovascular and metabolic diseases, cancer, neurobiology and development, systems biology and medicinal chemistry. It also houses three specialized research clinics, seven core facilities and three research platforms with state-of-the-art equipment. The IRCM employs 425 people and is an independent institution affiliated with the Université de Montréal. The IRCM clinic is associated to the Centre hospitalier de l'Université de Montréal (CHUM). The IRCM also maintains a long-standing association with McGill University.
Julie Langelier | EurekAlert!
Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH
Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute
An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...
Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...
Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.
While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...
Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales
Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...
Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.
As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...
19.01.2017 | Event News
10.01.2017 | Event News
09.01.2017 | Event News
20.01.2017 | Awards Funding
20.01.2017 | Materials Sciences
20.01.2017 | Life Sciences